If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi™ (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
BAQSIMI™ (glucagon) nasal powder: Position After Administration
It is recommended to turn the person on their side after administering Baqsimi (glucagon nasal powder).
If the person is unconscious, it is recommended to turn the person on their side after administering the dose of Baqsimi.1
Enclosed Prescribing Information
BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly
1. Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 8am - 7pm ET
